- Shire plc (NASDAQ:SHPG) is up 2% premarket on light volume on the heels of its announcement of three poster presentations on ADHD med MYDAYIS (mixed salts of a single-entity amphetamine product) at Psych Congress in New Orleans on Sunday, September 17.
- The FDA approved once-daily MYDAYIS in June.